KFSHRC Celebrates Landmark Contributions at 2024 NYC C3 Summit Davos of Healthcare
18 sept. 2024 06h00 HE
|
King Faisal Specialist Hospital & Research Centre
KFSHRC Celebrates Landmark Contributions at 2024 NYC C3 Summit Davos of Healthcare
Canadian Scientist Franco Cavaleri Expands Biomedical Research into Cancer Studies through International Collaboration with Indian University
17 sept. 2024 08h25 HE
|
Biologic Pharmamedical Inc.
Franco Cavaleri expands cancer research with India, offering post-doc opportunities, advancing biomedical science & fostering global healthcare innovation.
KFSHRC Redefines Global Healthcare with AI and Robotic Surgery Innovations
16 sept. 2024 15h06 HE
|
King Faisal Specialist Hospital & Research Centre
KFSHRC Redefines Global Healthcare with AI and Robotic Surgery Innovations
KFSHRC Leads as a Premier Destination for Medical Tourism and Innovative Care Solutions
15 sept. 2024 07h05 HE
|
King Faisal Specialist Hospital & Research Centre
KFSHRC Leads as a Premier Destination for Medical Tourism and Innovative Care Solutions
KFSHRC Revolutionizes Patient Care with Pioneering Experience Ambassadors Program
14 sept. 2024 07h11 HE
|
King Faisal Specialist Hospital & Research Centre
KFSHRC Revolutionizes Patient Care with Pioneering Experience Ambassadors Program
KFSHRC Pioneering Ethical Innovation in Global Healthcare
13 sept. 2024 07h42 HE
|
King Faisal Specialist Hospital & Research Centre
KFSHRC Pioneering Ethical Innovation in Global Healthcare
MetasTx Welcomes Esteemed Cancer Scientist Dr. Jonathan Chernoff to the Board of Managers
13 sept. 2024 07h13 HE
|
MetasTx LLC
Dr. Chernoff’s decision to join the Board of Managers reflects his strong belief in MetasTx’s science and strategic direction.
Harvey Homan to Highlight MetasTx’s Game-Changing Approach to Cancer Treatment at PA Life Science Futures
12 sept. 2024 06h58 HE
|
MetasTx LLC
MetasTx aims to revolutionize cancer treatment by targeting p21-activated kinase (PAK-1), a critical driver of metastasis in solid tumors.
Le PIONeeR Project présentera pour la première fois les résultats de son étude clinique de phase Ib/IIa lors de l’ESMO 2024
12 sept. 2024 04h21 HE
|
The PIONeeR Project
Le PIONeeR Project présentera pour la première fois les résultats de son étude clinique de phase Ib/IIa lors de l’ESMO 2024 Le symposium présidentiel "Eyes to the future" sera l'occasion de présenter...
The PIONeeR Project to Present Late-Breaking Results from its Phase Ib/IIa umbrella study at the ESMO Congress 2024
12 sept. 2024 04h21 HE
|
The PIONeeR Project
The PIONeeR Project to Present Late-Breaking Results from its Phase Ib/IIa umbrella study at the ESMO Congress 2024 The Presidential Symposium "Eyes to the future" will feature the first-ever...